Alexandria Real Estate Equities lowered its annual adjusted funds from operations forecast, missing Wall Street estimates due to persistent macroeconomic uncertainty and high interest rates. The life science REIT reported negative net absorption and a quarterly net loss, impacting its share price. Pharma clients also face potential cost increases from proposed tariffs.
